Literature DB >> 22733233

Breast cancer in young women.

Steven A Narod1.   

Abstract

About one in 300 women will be diagnosed with breast cancer before the age of 40. Advances in screening have not had an impact on mortality in women who are too young to be candidates for screening. Risk factors for early breast cancer include a lean body habitus and recent use of an oral contraceptive. Breast cancers in very young women are typically aggressive, in part owing to the over-representation of high-grade, triple-negative tumours, but young age is an independent negative predictor of cancer-specific survival. Very early age-of-onset also correlates strongly with the risk of local recurrence and with the odds of contralateral breast cancer. Given the high risks of local and distant recurrence in young women with invasive breast cancer, most (if not all) young patients are candidates for chemotherapy. It is hoped that by increasing breast cancer awareness, the proportion of invasive breast cancers that are diagnosed at 2.0 cm or smaller will increase and that this will lead to a reduction in mortality.

Entities:  

Mesh:

Year:  2012        PMID: 22733233     DOI: 10.1038/nrclinonc.2012.102

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  87 in total

1.  Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Authors:  Andrew H Beck; Ankur R Sangoi; Samuel Leung; Robert J Marinelli; Torsten O Nielsen; Marc J van de Vijver; Robert B West; Matt van de Rijn; Daphne Koller
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden).

Authors:  Qin Liu; Joanne Wuu; Mats Lambe; Shu-Feng Hsieh; Anders Ekbom; Chung-Cheng Hsieh
Journal:  Cancer Causes Control       Date:  2002-05       Impact factor: 2.506

3.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Authors:  Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

4.  Genetic implications of bilateral breast cancer: a population based cohort study.

Authors:  Mikael Hartman; Kamila Czene; Marie Reilly; Jonas Bergh; Pagona Lagiou; Dimitrios Trichopoulos; Hans-Olov Adami; Per Hall
Journal:  Lancet Oncol       Date:  2005-06       Impact factor: 41.316

Review 5.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 7.  Obesity and breast cancer: a review of the literature.

Authors:  A R Carmichael; T Bates
Journal:  Breast       Date:  2004-04       Impact factor: 4.380

8.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

9.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

Review 10.  Radiation and breast cancer: a review of current evidence.

Authors:  Cécile M Ronckers; Christine A Erdmann; Charles E Land
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

View more
  53 in total

1.  Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Authors:  Chaya S Moskowitz; Joanne F Chou; Joseph P Neglia; Ann H Partridge; Rebecca M Howell; Lisa R Diller; Danielle Novetsky Friedman; Dana Barnea; Lindsay M Morton; Lucie M Turcotte; Michael A Arnold; Wendy M Leisenring; Gregory T Armstrong; Leslie L Robison; Kevin C Oeffinger; Tara O Henderson
Journal:  J Clin Oncol       Date:  2019-07-01       Impact factor: 44.544

2.  Is breast cancer staging obsolete?

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

3.  Breast Carcinoma in Young Women: No Evidence of Increasing Rates of Metastatic Breast Carcinoma in a Single Tertiary Center Review.

Authors:  Niamh Conlon; Jane Howard; Jeffrey Catalano; Meighan Gallagher; Lee K Tan; Adriana D Corben
Journal:  Breast J       Date:  2016-02-29       Impact factor: 2.431

4.  Employment trends in young women following a breast cancer diagnosis.

Authors:  Shoshana M Rosenberg; Ines Vaz-Luis; Jingyi Gong; Padma Sheila Rajagopal; Kathryn J Ruddy; Rulla M Tamimi; Lidia Schapira; Steven Come; Virginia Borges; Janet S de Moor; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2019-05-30       Impact factor: 4.872

5.  Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.

Authors:  Xiaohong R Yang; Jonine D Figueroa; Stephen M Hewitt; Roni T Falk; Ruth M Pfeiffer; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2012-12-28       Impact factor: 4.872

Review 6.  Breast cancer in adolescents and young adults.

Authors:  Rebecca H Johnson; Carey K Anders; Jennifer K Litton; Kathryn J Ruddy; Archie Bleyer
Journal:  Pediatr Blood Cancer       Date:  2018-08-28       Impact factor: 3.167

Review 7.  Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.

Authors:  Soumaya Ben Abdelkrim; Khadija Fathallah; Rim Rouatbi; Malak Ayachi; Sihem Hmissa; Moncef Mokni
Journal:  Pathol Oncol Res       Date:  2015-05-12       Impact factor: 3.201

8.  Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013.

Authors:  Meredith L Shoemaker; Mary C White; Manxia Wu; Hannah K Weir; Isabelle Romieu
Journal:  Breast Cancer Res Treat       Date:  2018-02-14       Impact factor: 4.872

9.  Epidemiology and prognosis of breast cancer in young women.

Authors:  Hussein A Assi; Katia E Khoury; Haifa Dbouk; Lana E Khalil; Tarek H Mouhieddine; Nagi S El Saghir
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 10.  Bilateral breast cancers.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2014-02-04       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.